nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
|
Chou, Stella T. |
|
|
4 |
2 |
p. 327-355 |
artikel |
2 |
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines
|
Diepstraten, Sarah T. |
|
|
4 |
2 |
p. 356-366 |
artikel |
3 |
Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses
|
Weycker, Derek |
|
|
4 |
2 |
p. 432-439 |
artikel |
4 |
Clinical and functional significance of circular RNAs in cytogenetically normal AML
|
Papaioannou, Dimitrios |
|
|
4 |
2 |
p. 239-251 |
artikel |
5 |
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial
|
Gianfaldoni, Giacomo |
|
|
4 |
2 |
p. 301-311 |
artikel |
6 |
Editorial Board
|
|
|
|
4 |
2 |
p. i |
artikel |
7 |
Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia
|
McCalmont, Hannah |
|
|
4 |
2 |
p. 296-300 |
artikel |
8 |
Evaluation of cyclin A1–specific T cells as a potential treatment for acute myeloid leukemia
|
Leung, Wingchi K. |
|
|
4 |
2 |
p. 387-397 |
artikel |
9 |
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia
|
Çelik, Haydar |
|
|
4 |
2 |
p. 367-379 |
artikel |
10 |
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival
|
Brück, Oscar |
|
|
4 |
2 |
p. 274-286 |
artikel |
11 |
Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation
|
Ando, Taiki |
|
|
4 |
2 |
p. 408-419 |
artikel |
12 |
Long-term outcomes after autologous stem cell transplantation for multiple myeloma
|
Nishimura, Katherine K. |
|
|
4 |
2 |
p. 422-431 |
artikel |
13 |
N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm
|
Craver, Brianna M. |
|
|
4 |
2 |
p. 312-321 |
artikel |
14 |
Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.
|
|
|
|
4 |
2 |
p. 252 |
artikel |
15 |
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics
|
Torka, Pallawi |
|
|
4 |
2 |
p. 253-262 |
artikel |
16 |
P-selectin–deficient mice to study pathophysiology of sickle cell disease
|
Bennewitz, Margaret F. |
|
|
4 |
2 |
p. 266-273 |
artikel |
17 |
Recapitulation of posttransfusion purpura by cross-strain platelet immunization in mice
|
Bougie, Daniel W. |
|
|
4 |
2 |
p. 287-295 |
artikel |
18 |
Response to “Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study”
|
Neofytos, Dionysios |
|
|
4 |
2 |
p. 420-421 |
artikel |
19 |
Ruxolitinib for the prevention of thrombosis in polycythemia vera: a systematic review and meta-analysis
|
Masciulli, Arianna |
|
|
4 |
2 |
p. 380-386 |
artikel |
20 |
Sex differences in the trajectory of glomerular filtration rate in pediatric and murine sickle cell anemia
|
Kasztan, Malgorzata |
|
|
4 |
2 |
p. 263-265 |
artikel |
21 |
Utility of serum free light chain ratio in response definition in patients with multiple myeloma
|
Abdallah, Nadine |
|
|
4 |
2 |
p. 322-326 |
artikel |
22 |
von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome
|
Taylor, Alice |
|
|
4 |
2 |
p. 398-407 |
artikel |